It found INSUFFICIENT EVIDENCE to support that cannabis/cannabinoids are effective treatment for:

• Cancers, including glioma (cannabinoids).

• Cancer-associated anorexia cachexia syndrome and anorexia nervosa (cannabinoids).

• Symptoms of irritable bowel syndrome (dronabinol).

• Epilepsy (cannabinoids).

• Spasticity in patients with paralysis due to spinal cord injury (cannabinoids).

• Symptoms associated with amyotrophic lateral sclerosis (cannabinoids).

• Chorea and certain neuropsychiatric symptoms associated with Huntington’s disease (oral cannabinoids).

• Motor system symptoms associated with Parkinson’s disease or the levodopa-induced dyskinesia (cannabinoids).

• Dystonia (nabilone and dronabinol).

• Achieving abstinence in the use of addictive substances (cannabinoids).

• Mental health outcomes in individuals with schizophrenia or schizophreniform psychosis (cannabidiol).

" The National Academy of Science called for more and better research.